All In Biotech

Drug Trial Radar · NCT07838155

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

A Phase 4, Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety and Tolerability of Donanemab in Indian Participants With Early Symptomatic Alzheimer's Disease

Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Sep 2030

Study completion Sep 2030

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Sep 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 60 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess how well Donanemab is tolerated and what side effects may occur in Indian participants with early symptoms of Alzheimer's Disease (AD). For each participant, the study will last up to approximately 84 weeks and will include visits every 4 weeks.

Conditions

  • Alzheimer Disease

Interventions

  • DonanemabDrug

    Donanemab administered IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Any Occurrence of Amyloid-Related Imaging Abnormalities (ARIA)Time frame: Baseline Up to Week 24, 52
  2. Frequency and Severity of Infusion-Related ReactionsTime frame: Through Week 52

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Manipal Hospital

    Bangalore, India

  • NIMHANS

    Bangalore, India

  • Aster CMI Hospital

    Bangalore, India

  • Yashoda Hospital Somajiguda, Hyderabad

    Hyderabad, India

  • Bangur Institute of Neurosciences (BIN) and Institute of Post Graduate Medical Education and Research (IPGME&R)

    Kolkata, India

  • Apollo Multispeciality Hospitals limited

    Kolkata, India

  • Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute

    Mumbai, India

  • Institute of Human Behaviour and Allied Sciences

    New Delhi, India

  • All India Institute of Medical Sciences (AIIMS), New Delhi

    New Delhi, India

  • Indraprastha Apollo Hospital

    New Delhi, India

  • Apollo Speciality Hospital - Teynampet

    Tamil Nadu, India

  • Christian Medical College Vellore

    Vellore, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.